ORGENESIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5 USD | -1.40% |
|
-1.42% | -0.14% |
| Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
| Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 72.87 | 75.31 | 108.7 | 69.91 | 49.81 | 15.96 |
| Enterprise Value (EV) 1 | 63.02 | 88.7 | 76.69 | 76.28 | 64.78 | 37.74 |
| P/E ratio | -2.05 x | -2.63 x | 15.3 x | -3.87 x | -3.29 x | -0.26 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.28 x | 2.26 x | 14.2 x | 1.97 x | 1.38 x | 30.1 x |
| EV / Revenue | 2.84 x | 2.67 x | 10 x | 2.15 x | 1.8 x | 71.2 x |
| EV / EBITDA | -1.95 x | -4.26 x | -0.81 x | -4.9 x | -11.6 x | -0.75 x |
| EV / FCF | -3.65 x | -12.5 x | 27.3 x | -2.3 x | -1.89 x | 6.55 x |
| FCF Yield | -27.4% | -7.99% | 3.67% | -43.5% | -52.8% | 15.3% |
| Price to Book | 2.76 x | 15.6 x | 2.07 x | 1.82 x | 1.81 x | -0.76 x |
| Nbr of stocks (in thousands) | 15,571 | 16,161 | 24,156 | 24,275 | 25,546 | 31,877 |
| Reference price 2 | 4.680 | 4.660 | 4.500 | 2.880 | 1.950 | 0.5007 |
| Announcement Date | 3/9/20 | 3/9/20 | 3/9/21 | 3/30/22 | 3/22/23 | 4/15/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 22.22 | 33.26 | 7.652 | 35.5 | 36.02 | 0.53 |
| EBITDA 1 | -32.38 | -20.8 | -94.56 | -15.58 | -5.563 | -50.64 |
| EBIT 1 | -35.56 | -24.6 | -95.1 | -16.8 | -7.541 | -52.2 |
| Operating Margin | -159.99% | -73.98% | -1,242.8% | -47.32% | -20.93% | -9,849.62% |
| Earnings before Tax (EBT) 1 | -35.88 | -25.48 | -96.74 | -17.95 | -11.96 | -64.44 |
| Net income 1 | -32.93 | -24.12 | 1.11 | -18.05 | -14.89 | -55.36 |
| Net margin | -148.16% | -72.53% | 14.51% | -50.85% | -41.33% | -10,445.47% |
| EPS 2 | -2.280 | -1.774 | 0.2941 | -0.7437 | -0.5933 | -1.908 |
| Free Cash Flow 1 | -17.26 | -7.083 | 2.811 | -33.16 | -34.21 | 5.763 |
| FCF margin | -77.67% | -21.3% | 36.74% | -93.4% | -94.97% | 1,087.31% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | 253.28% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/9/20 | 3/9/20 | 3/9/21 | 3/30/22 | 3/22/23 | 4/15/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8.676 | 6.892 | 7.212 | 7.201 | 7.988 | 13.62 | 7.044 | 6.975 | 0.11 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -7.656 | -6.906 | -3.236 | -4.732 | -0.007 | 0.434 | -3.205 | -3.329 | -2.235 |
| Operating Margin | -88.24% | -100.2% | -44.87% | -65.71% | -0.09% | 3.19% | -45.5% | -47.73% | -2,031.82% |
| Earnings before Tax (EBT) 1 | -10.08 | -4.975 | -3.996 | -5.481 | -1.383 | -1.1 | -4.132 | -3.57 | -12.26 |
| Net income 1 | -10.16 | -5.016 | -4.009 | -5.427 | -1.356 | -4.097 | -4.189 | -4.127 | -12.65 |
| Net margin | -117.09% | -72.78% | -55.59% | -75.36% | -16.98% | -30.07% | -59.47% | -59.17% | -11,502.73% |
| EPS 2 | -0.4200 | -0.2000 | -0.1600 | -0.2200 | -0.0500 | -0.1600 | -0.1600 | -0.1500 | -0.4300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 3/30/22 | 5/23/22 | 8/15/22 | 11/10/22 | 3/22/23 | 5/10/23 | 8/10/23 | 11/13/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 13.4 | - | 6.37 | 15 | 21.8 |
| Net Cash position 1 | 9.86 | - | 32 | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.6438 x | - | -0.4087 x | -2.689 x | -0.4301 x |
| Free Cash Flow 1 | -17.3 | -7.08 | 2.81 | -33.2 | -34.2 | 5.76 |
| ROE (net income / shareholders' equity) | -54.2% | -59.2% | -212% | -39.5% | -24.9% | -339% |
| ROA (Net income/ Total Assets) | -15.1% | -18.5% | -69.9% | -15.3% | -6.25% | -61.9% |
| Assets 1 | 218.2 | 130.5 | -1.589 | 118.2 | 238.1 | 89.49 |
| Book Value Per Share 2 | 1.690 | 0.3000 | 2.180 | 1.590 | 1.080 | -0.6600 |
| Cash Flow per Share 2 | 0.9500 | 0.6200 | 1.860 | 0.2300 | 0.2100 | 0.0300 |
| Capex 1 | 6.42 | 12.1 | 1.53 | 7.87 | 12.4 | 2.1 |
| Capex / Sales | 28.89% | 36.47% | 19.93% | 22.16% | 34.46% | 395.47% |
| Announcement Date | 3/9/20 | 3/9/20 | 3/9/21 | 3/30/22 | 3/22/23 | 4/15/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -0.14% | 17.27M | |
| -2.54% | 187B | |
| -1.85% | 106B | |
| -4.26% | 66.9B | |
| +1.39% | 49.45B | |
| +16.82% | 48B | |
| +5.82% | 40.84B | |
| +3.49% | 26.48B | |
| +0.65% | 26.25B | |
| +17.35% | 24.62B |
- Stock Market
- Equities
- ORGS Stock
- Financials Orgenesis Inc.
